Artificial Intelligence in Diagnosis of Long QT Syndrome: A Review of Current State, Challenges, and Future Perspectives

Long QT syndrome (LQTS) is a potentially life-threatening cardiac repolarization disorder characterized by an increased risk of fatal arrhythmias. Accurate and timely diagnosis is essential for risk stratification and appropriate management. However, traditional diagnostic approaches have limitation...

Full description

Bibliographic Details
Main Authors: Negar Raissi Dehkordi, MD, Nastaran Raissi Dehkordi, MD, Kimia Karimi Toudeshki, MD, Mohammad Hadi Farjoo, MD, PhD
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Mayo Clinic Proceedings: Digital Health
Online Access:http://www.sciencedirect.com/science/article/pii/S2949761223000937
_version_ 1797237805358776320
author Negar Raissi Dehkordi, MD
Nastaran Raissi Dehkordi, MD
Kimia Karimi Toudeshki, MD
Mohammad Hadi Farjoo, MD, PhD
author_facet Negar Raissi Dehkordi, MD
Nastaran Raissi Dehkordi, MD
Kimia Karimi Toudeshki, MD
Mohammad Hadi Farjoo, MD, PhD
author_sort Negar Raissi Dehkordi, MD
collection DOAJ
description Long QT syndrome (LQTS) is a potentially life-threatening cardiac repolarization disorder characterized by an increased risk of fatal arrhythmias. Accurate and timely diagnosis is essential for risk stratification and appropriate management. However, traditional diagnostic approaches have limitations, necessitating more objective and efficient tools. Artificial intelligence (AI) offers promising solutions by enhancing the accuracy and efficiency of electrocardiography (ECG) interpretation. The AI algorithms can process ECG data more rapidly than human experts, providing real-time analysis and prompt identification of individuals at risk, and reducing interobserver variability. By analyzing large volumes of ECG data, AI algorithms can extract meaningful features that may not be apparent to the human eye. Advancements in AI-driven corrected QT interval monitoring using mobile ECG devices, such as smartwatches, offer a valuable and convenient tool for identifying individuals at risk of LQTS-related complications, which is particularly applicable during pandemic conditions, such as COVID-19. Integration of AI into clinical practice poses a number of challenges. Bias in data gathering and patient privacy concerns are important considerations that must be addressed. Safeguarding patient privacy and ensuring data protection are crucial for maintaining trust in AI-driven systems. In addition, the interpretability of AI algorithms is a concern because understanding the decision-making process is essential for clinicians to trust and confidently use these tools. Future perspectives in this field may involve the integration of AI into diagnostic protocols, through genetic subtype classifications on the basis of ECG data. Moreover, explainable AI techniques aim to uncover ECG features associated with LQTS diagnosis, suggesting new insights into LQTS pathophysiology.
first_indexed 2024-04-24T17:25:35Z
format Article
id doaj.art-2473d4b92ec6414289a58994d48730c6
institution Directory Open Access Journal
issn 2949-7612
language English
last_indexed 2024-04-24T17:25:35Z
publishDate 2024-03-01
publisher Elsevier
record_format Article
series Mayo Clinic Proceedings: Digital Health
spelling doaj.art-2473d4b92ec6414289a58994d48730c62024-03-28T06:40:55ZengElsevierMayo Clinic Proceedings: Digital Health2949-76122024-03-01212131Artificial Intelligence in Diagnosis of Long QT Syndrome: A Review of Current State, Challenges, and Future PerspectivesNegar Raissi Dehkordi, MD0Nastaran Raissi Dehkordi, MD1Kimia Karimi Toudeshki, MD2Mohammad Hadi Farjoo, MD, PhD3Department of Pharmacology, Shahid Beheshti University of Medical Sciences, Tehran, IranDepartment of Pharmacology, Shahid Beheshti University of Medical Sciences, Tehran, IranDepartment of Cardiology, Shohadaye Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IranDepartment of Pharmacology, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Correspondence: Address to Mohammad Hadi Farjoo, Md, PhD, Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Kodakyar Street, Daneshjoo Blvd, Velenjak, Tehran-Iran, 19835355.Long QT syndrome (LQTS) is a potentially life-threatening cardiac repolarization disorder characterized by an increased risk of fatal arrhythmias. Accurate and timely diagnosis is essential for risk stratification and appropriate management. However, traditional diagnostic approaches have limitations, necessitating more objective and efficient tools. Artificial intelligence (AI) offers promising solutions by enhancing the accuracy and efficiency of electrocardiography (ECG) interpretation. The AI algorithms can process ECG data more rapidly than human experts, providing real-time analysis and prompt identification of individuals at risk, and reducing interobserver variability. By analyzing large volumes of ECG data, AI algorithms can extract meaningful features that may not be apparent to the human eye. Advancements in AI-driven corrected QT interval monitoring using mobile ECG devices, such as smartwatches, offer a valuable and convenient tool for identifying individuals at risk of LQTS-related complications, which is particularly applicable during pandemic conditions, such as COVID-19. Integration of AI into clinical practice poses a number of challenges. Bias in data gathering and patient privacy concerns are important considerations that must be addressed. Safeguarding patient privacy and ensuring data protection are crucial for maintaining trust in AI-driven systems. In addition, the interpretability of AI algorithms is a concern because understanding the decision-making process is essential for clinicians to trust and confidently use these tools. Future perspectives in this field may involve the integration of AI into diagnostic protocols, through genetic subtype classifications on the basis of ECG data. Moreover, explainable AI techniques aim to uncover ECG features associated with LQTS diagnosis, suggesting new insights into LQTS pathophysiology.http://www.sciencedirect.com/science/article/pii/S2949761223000937
spellingShingle Negar Raissi Dehkordi, MD
Nastaran Raissi Dehkordi, MD
Kimia Karimi Toudeshki, MD
Mohammad Hadi Farjoo, MD, PhD
Artificial Intelligence in Diagnosis of Long QT Syndrome: A Review of Current State, Challenges, and Future Perspectives
Mayo Clinic Proceedings: Digital Health
title Artificial Intelligence in Diagnosis of Long QT Syndrome: A Review of Current State, Challenges, and Future Perspectives
title_full Artificial Intelligence in Diagnosis of Long QT Syndrome: A Review of Current State, Challenges, and Future Perspectives
title_fullStr Artificial Intelligence in Diagnosis of Long QT Syndrome: A Review of Current State, Challenges, and Future Perspectives
title_full_unstemmed Artificial Intelligence in Diagnosis of Long QT Syndrome: A Review of Current State, Challenges, and Future Perspectives
title_short Artificial Intelligence in Diagnosis of Long QT Syndrome: A Review of Current State, Challenges, and Future Perspectives
title_sort artificial intelligence in diagnosis of long qt syndrome a review of current state challenges and future perspectives
url http://www.sciencedirect.com/science/article/pii/S2949761223000937
work_keys_str_mv AT negarraissidehkordimd artificialintelligenceindiagnosisoflongqtsyndromeareviewofcurrentstatechallengesandfutureperspectives
AT nastaranraissidehkordimd artificialintelligenceindiagnosisoflongqtsyndromeareviewofcurrentstatechallengesandfutureperspectives
AT kimiakarimitoudeshkimd artificialintelligenceindiagnosisoflongqtsyndromeareviewofcurrentstatechallengesandfutureperspectives
AT mohammadhadifarjoomdphd artificialintelligenceindiagnosisoflongqtsyndromeareviewofcurrentstatechallengesandfutureperspectives